THE ADDITIONAL IMPACT OF CHRONIC KIDNEY DISEASE ON CARDIOVASCULAR OUTCOMES AND DEATH AMONG HCV PATIENTS

被引：0
|
作者：
Tartof, S. [1 ]
Arduino, J. M. [2 ]
Wei, R. [1 ]
Hsu, J. -W. [1 ]
Rubenstein, K. [3 ]
Hu, H. [3 ]
Horberg, M. [3 ]
Derose, S. [1 ]
Rodriguez, C. [3 ]
机构：
[1] Kaiser Permanente Southern Calif, Dept Res & Evaluat, Pasadena, CA USA
[2] Merck & Co Inc, Kenilworth, NJ USA
[3] Kaiser Permanente Midatlantic States, Midatlantic Permanente Res Inst, Rockville, MD USA
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
10.1016/S0168-8278(16)01161-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-193
引用
收藏
页码：S624 / S624
页数：1
相关论文
共 50 条
  • [41] Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes
    Filippatos, Gerasimos
    Anker, Stefan D.
    Agarwal, Rajiv
    Pitt, Bertram
    Ruilope, Luis M.
    Rossing, Peter
    Kolkhof, Peter
    Schloemer, Patrick
    Tornus, Ingo
    Joseph, Amer
    Bakris, George L.
    [J]. CIRCULATION, 2021, 143 (06) : 540 - 552
  • [42] Circulating ADAMs are associated with renal and cardiovascular outcomes in chronic kidney disease patients
    Palau, Vanesa
    Riera, Marta
    Duran, Xavier
    Manuel Valdivielso, Jose
    Betriu, Angels
    Fernandez, Elvira
    Pascual, Julio
    Jose Soler, Maria
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (01) : 130 - 138
  • [43] Racial and Ethnic Disparities in Cardiovascular Disease Risk Among Patients with Chronic Kidney Disease
    Adedinsewo, Demilade A.
    Porter, Ivan E., II
    White, Richard O.
    Hickson, LaTonya J.
    [J]. CURRENT CARDIOVASCULAR RISK REPORTS, 2022, 16 (11) : 145 - 157
  • [44] Risk for recurrent cardiovascular disease events among patients with diabetes and chronic kidney disease
    Demetria Hubbard
    Lisandro D. Colantonio
    Robert S. Rosenson
    Todd M. Brown
    Elizabeth A. Jackson
    Lei Huang
    Kate K. Orroth
    Stephanie Reading
    Mark Woodward
    Vera Bittner
    Orlando M. Gutierrez
    Monika M. Safford
    Michael E. Farkouh
    Paul Muntner
    [J]. Cardiovascular Diabetology, 20
  • [45] SERUM LIPIDS DO NOT PREDICT CARDIOVASCULAR OUTCOMES IN CHRONIC KIDNEY DISEASE PATIENTS
    Landray, Martin J.
    Blackwell, Lisa
    Morgan, Matthew
    Nuttall, Sarah
    Baigent, Colin
    Townend, John
    Wheeler, David C.
    [J]. NEPHROLOGY, 2005, 10 : A152 - A152
  • [46] The impact of exercise on physical function, cardiovascular outcomes and quality of life in chronic kidney disease patients: a systematic review
    Baris Afsar
    Dimitrie Siriopol
    Gamze Aslan
    Ozgur C. Eren
    Tuncay Dagel
    Ugur Kilic
    Asiye Kanbay
    Alexandru Burlacu
    Adrian Covic
    Mehmet Kanbay
    [J]. International Urology and Nephrology, 2018, 50 : 885 - 904
  • [47] Risk for recurrent cardiovascular disease events among patients with diabetes and chronic kidney disease
    Hubbard, Demetria
    Colantonio, Lisandro D.
    Rosenson, Robert S.
    Brown, Todd M.
    Jackson, Elizabeth A.
    Huang, Lei
    Orroth, Kate K.
    Reading, Stephanie
    Woodward, Mark
    Bittner, Vera
    Gutierrez, Orlando M.
    Safford, Monika M.
    Farkouh, Michael E.
    Muntner, Paul
    [J]. CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [48] Racial and Ethnic Disparities in Cardiovascular Disease Risk Among Patients with Chronic Kidney Disease
    Demilade A. Adedinsewo
    Ivan E. Porter
    Richard O. White
    LaTonya J. Hickson
    [J]. Current Cardiovascular Risk Reports, 2022, 16 : 145 - 157
  • [49] Impact of non-invasive cardiovascular screening programs as a predictor of cardiovascular events among asymptomatic chronic kidney disease patients
    Akihiro Sawai
    Yoshinari Yasuda
    Susumu Suzuki
    Hideki Ishii
    Motomitsu Goto
    Sawako Kato
    Mutsuharu Hayashi
    Shoichi Maruyama
    Toyoaki Murohara
    Yutaka Oiso
    Seiichi Matsuo
    [J]. Clinical and Experimental Nephrology, 2016, 20 : 416 - 424
  • [50] The effects of dapagliflozin on kidney and cardiovascular outcomes in patients with chronic kidney disease with and without heart failure
    Heerspink, J. L.
    Wheeler, D. C.
    Vart, P.
    Jongs, N.
    Hou, F. F.
    Langkilde, A. M.
    Correa-Rotter, R.
    Rossing, P.
    Sjostrom, C. D.
    Toto, R. D.
    Chertow, G. M.
    Stefansson, B. V.
    McMurray, J. J. V.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 2913 - 2913
12345